Clinical Trial Update: Gemcitabine and Nab-Paclitaxel Combined With Iparomlimab and Tuvorilimab for Advanced Gallbladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a regimen of gemcitabine and nab-paclitaxel with iparomlimab and tuvorilimab in unresectable advanced gallbladder cancer. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gallbladder Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Nab-paclitaxel (paclitaxel protein-bound)
• Tuvorilimab (tuvorilimab)
• iparomlimab

Snippet

Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Gallbladder Cancer Unresectable | Phase 2 | Status: ENROLLING_BY_INVITATION